Sterling Healthcare Services announces the launch of CDS-20, their COVID-19 governance service

Sterling Healthcare has launched its Coronavirus Governance Service (CDS-20). The CDS-20 service fulfills the needs of hospitals and other provider groups who need to integrate COVID-19 financial reporting, auditing, analytics, and continuity capabilities into a compliance-based framework. In an urgent response to CMS’s new COVID-19 codes, Sterling Healthcare recognizes a[…]

Read more

Octarine Bio IVS Receives Funding from Vækstfonden to Develop Biosynthetic Platform for Cannabinoid and Psychedelic Tryptamine Derivatives

Octarine Bio IVS, a synthetic biology company developing functionally superior cannabinoid and psychedelic tryptamine derivatives has received funding from Danish State’s investment fund, Vækstfonden. COPENHAGEN, DENMARK (PRWEB) MARCH 11, 2020 Today, Octarine Bio IVS, a synthetic biology company developing functionally superior cannabinoid and psychedelic tryptamine derivatives, announced that the company has[…]

Read more

Polysense Announces Infrared Thermal Temperature Screening WxS x810-IRTM, enabling fast temperature monitoring of both mobile population and fixed locations

Powered by the same IoT edge computing technology, WxS x800-IRTM and WxS x800-IRTMS allows global agencies and communities to effectively handle any public health emergency, meeting the urgent requirements for populations temperature screening at this corona virus or Flu public healths period SANTA CLARA, CALIF. (PRWEB) MARCH 11, 2020 Polysense Technologies[…]

Read more

Transformation Begins at Nikola Tesla’s Historic NY Laboratory as New ESD Grant Propels Renovations for a Global Museum and Science Center

Tesla Science Center at Wardenclyffe (TSCW) received an Empire State Development (ESD) grant designated for use in the renovation of Wardenclyffe, the last remaining laboratory of renowned inventor Nikola Tesla, into three unique attractions: a museum honoring Tesla and his legacy; a center for education and research; and an accelerator and[…]

Read more

Optimizing the Success of Phase I Hybrid Trials: The Role of a Comprehensive Early Development Plan, Upcoming Webinar Hosted by Xtalks

In this webinar, the speakers will focus on how a comprehensive development plan (CDP) can increase efficiency and success rates in early drug development. They will also explain how Phase I Healthy Volunteer and Patient Hybrid Trials provide signals of potential efficacy and how CDPs are prepared. TORONTO (PRWEB) MARCH 13,[…]

Read more